Clinical Trial of Peripheral Prism Glasses for Hemianopia

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

April 30, 2010

Conditions
Homonymous Hemianopia
Interventions
DEVICE

High power (57 prism diopter) peripheral prism glasses

All patients will wear two pairs of prism glasses in a crossover design: the high power peripheral prism glasses and sham peripheral prism glasses. Each pair of prism glasses will be worn for four weeks

DEVICE

Low power sham peripheral prism glasses

Low power (5 prism dioptre) prism glasses that provide only about 2 degrees of visual field expansion.

Trial Locations (13)

27376

Seven Lakes Eye Care, West End

27707

Academy Eye Associates, Durham

30322

Emory Optical Low Vision, Atlanta

33458

Visual Health@Jupiter Eye Center, Jupiter

35294

UAB Center for Low Vision Rehabilitation, Birmingham

47404

Indiana University School of Optometry, Low Vision Rehabilitation and Primary Care Services, Bloomington

60616

Illinois Eye Institute, Chicago

66208

University of Kansas Medical Center, Prairie Village

74464

NSU Oklahoma College of Optometry,, Tahlequah

94306

Vista Center for the Blind and Visually Impaired, Palo Alto

02114

Schepens Eye Research Institute, Boston

01772

Vision Care Specialists, P.C., Southborough

M60 1QD

Manchester Royal Eye Hospital, Manchester

All Listed Sponsors
collaborator

Chadwick Optical Inc.

INDUSTRY

collaborator

National Eye Institute (NEI)

NIH

lead

Alexandra Bowers

OTHER

NCT00494676 - Clinical Trial of Peripheral Prism Glasses for Hemianopia | Biotech Hunter | Biotech Hunter